- Fever of Unknown Origin (FUO)12:55Polycystic Kidney Disease (PKD), Part 1Free Chapter13:13Paper Chase #1 | Biotin Supplements Screw up Lab Tests? What the…?5:35Living with Cystic Fibrosis: Part II15:45Ectopic Pregnancy20:58Paper Chase #2 | Transdermal Estrogen Keeps the Sex Drive Alive6:58Case of the Month - Hidradenitis Suppurativa19:47Polycystic Kidney Disease (PKD), Part 212:22Paper Chase #3 | The COMPASS Trial5:47Spinal Stenosis13:25Family Medical Leave Act (FMLA)19:03Paper Chase #4 | Are All influenza Tests Created Equal?5:33Grave’s Disease - Part 214:51Deprescribing14:48Paper Chase #5 | Concerning a Cholesterol Drug We’ve Never Heard Of: Anacetrapib5:08The Summary17:36
Adding Rivaroxaban to aspirin therapy resulted in 1% fewer composite cardiovascular outcomes, but cause a 1% increase in bleeds. Andrew and Joe conclude that Rivaroxaban does not offer benefits above aspirin alone in the study population.
A Feverish Frenzy! Full episode audio for MD edition 203:03 min - 95 MB - M4AHippo Primary Care RAP - January 2018 Summary 386 KB - PDF